Cargando…

Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review

We compared head-to-head the most used radiolabeled peptides for single photon computed emission tomography (SPECT) and positron emission tomography (PET) imaging of neuroendocrine tumors (NETs). A comprehensive literature search was performed in PubMed, Web of Science, and Scopus databases. The fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poletto, Giulia, Cecchin, Diego, Sperti, Stefania, Filippi, Luca, Realdon, Nicola, Evangelista, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689511/ https://www.ncbi.nlm.nih.gov/pubmed/36354685 http://dx.doi.org/10.3390/cimb44110373

Ejemplares similares

Radionuclide Delivery Strategies in Tumor Treatment: A Systematic Review
por: Poletto, Giulia, et al.
Publicado: (2022)

SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
por: Alqahtani, Fawaz F.
Publicado: (2023)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
por: Pisaneschi, Federica, et al.
Publicado: (2021)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

Nanoparticles and Radioisotopes: A Long Story in a Nutshell
por: Poletto, Giulia, et al.
Publicado: (2022)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
por: Crișan, George, et al.
Publicado: (2022)

The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review
por: Evangelista, Laura, et al.
Publicado: (2021)

Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
por: Morbelli, Silvia, et al.
Publicado: (2020)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Head-to-Head Comparison between FDG and (11)C-Methionine in Multiple Myeloma: A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023)

Head-to-head comparison of myocardial perfusion SPECT and CMR for assessment of myocardial ischemia
por: Hedeer, Fredrik, et al.
Publicado: (2015)

Head-to-Head Comparison of CZT-SPECT and SPECT/CT Myocardial Perfusion Imaging: Interobserver and Intraobserver Agreement and Diagnostic Performance
por: Kalantari, Forough, et al.
Publicado: (2023)

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2021)

Head to head comparisons of two modalities of perfusion adenosine stress echocardiography with simultaneous SPECT
por: Gudmundsson, Petri, et al.
Publicado: (2009)

Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
por: Evans, Brendan J., et al.
Publicado: (2020)

Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison
por: Altomare, Daniele, et al.
Publicado: (2021)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT
por: Zacho, Helle D., et al.
Publicado: (2017)

Clinical evaluation of [(123)I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison
por: Adriaanse, Sofie M., et al.
Publicado: (2018)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Minutes to hours after a nuclear event: available radiation poisoning antidotes and practical considerations on possible urgent approaches
por: Taci, Xhoajda, et al.
Publicado: (2023)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

ACR testing of a dedicated head SPECT unit
por: Sensakovic, William F., et al.
Publicado: (2014)

Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals
por: Sardaro, Angela, et al.
Publicado: (2022)

One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for (99m)Tc radiolabelling of peptides
por: Hungnes, Ingebjørg N., et al.
Publicado: (2021)

Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
por: Brumberg, Joachim, et al.
Publicado: (2020)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Missing head and color banding in low-count SPECT reconstructions
por: de Nijs, Robin, et al.
Publicado: (2014)

Neuroendocrine Disruptions Following Head Injury
por: Wexler, Tamara L.
Publicado: (2023)

Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
por: Madsbad, Sten
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f4644g03o57kgjmongpv8fcvpo